Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study

被引：9
|
作者：
Overcast, Wynton B. [1 ]
Zhang, Jianying [2 ]
Zynger, Debra L. [3 ]
Tozbikian, Gary H. [3 ]
机构：
[1] Ohio State Univ, Coll Med, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, 320 Lincoln Tower,1800 Cannon Dr, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Wexner Med Ctr, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷 / 02期
关键词：
ASCO/CAP guidelines; Breast cancer; Equivocal category; HER2 immunohistochemistry (IHC); HER2 fluorescence in situ hybridization (FISH); IN-SITU HYBRIDIZATION; POLYMERASE CHAIN-REACTION; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; COPY NUMBER; CANCER; RECEPTOR; IMMUNOHISTOCHEMISTRY; TRASTUZUMAB; FISH;
D O I：
10.1007/s00428-016-1951-8
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 212
页数：10
相关论文
共 50 条
  • [21] How Do the Differences Between 2013 and 2007 ASCO/CAP HER2 Guidelines Affect Her2 Status in Breast Carcinomas?
    Onguru, Onder
    Zhang, Paul
    MODERN PATHOLOGY, 2015, 28 : 59A - 59A
  • [22] How Do the Differences Between 2013 and 2007 ASCO/CAP HER2 Guidelines Affect Her2 Status in Breast Carcinomas?
    Onguru, Onder
    Zhang, Paul
    LABORATORY INVESTIGATION, 2015, 95 : 59A - 59A
  • [23] Impact of the 2013 ASCO/CAP Guideline Recommendations for HER2 Testing of Invasive Breast Carcinoma: A Focus on Tumors Assessed as Equivocal for HER2 Gene Amplification By FISH
    Bethune, Gillian
    van Zanten, Daniel Veldheijzen
    Younis, Tallal
    Rayson, Daniel
    Thompson, Kara
    Barnes, Penny
    MODERN PATHOLOGY, 2015, 28 : 35A - 35A
  • [24] Impact of the updated 2018 ASCO/CAP guidelines for HER2 testing in breast cancer
    Li, Anqi
    Bai, Qianming
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2019, 99
  • [25] Impact of the updated 2018 ASCO/CAP guidelines for HER2 testing in breast cancer
    Li, Anqi
    Bai, Qianming
    Zhou, Xiaoyan
    Yang, Wentao
    MODERN PATHOLOGY, 2019, 32
  • [26] COMPARISON OF THE 2007 AND 2013 ASCO/CAP GUIDELINES FOR HER2 ISH TESTING IN INVASIVE BREAST CANCER PATIENTS
    Salido, M.
    Puiggros, A.
    Corominas, J. M.
    Iglesias, M.
    Rodriguez-Rivera, M.
    Melero, C.
    Tusquets Trias Bes, I.
    Albanell, J.
    Serrano, S.
    Servitja Tormo, S.
    Espinet, B.
    ANNALS OF ONCOLOGY, 2014, 25
  • [27] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Fang-Ping Xu
    Kun Wang
    Jie Xu
    Jie Chen
    Yi-Fang Zhang
    Hong-Mei Wu
    Ming-Hui Zhang
    Xiao-Xu Long
    Xin-Lan Luo
    Ke-Ping Zhang
    Dan-Yi Lin
    Yan-Hui Liu
    Breast Cancer Research and Treatment, 2017, 166 : 757 - 764
  • [28] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Xu, Fang-Ping
    Wang, Kun
    Xu, Jie
    Chen, Jie
    Zhang, Yi-Fang
    Wu, Hong-Mei
    Zhang, Ming-Hui
    Long, Xiao-Xu
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Lin, Dan-Yi
    Liu, Yan-Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (03) : 757 - 764
  • [29] Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+Invasive Breast Cancer
    Yamada, Mai
    Kubo, Makoto
    Yamamoto, Hidetaka
    Yamashita, Nami
    Kai, Masaya
    Zaguirre, Karen
    Kaneshiro, Kazuhisa
    Shimazaki, Akiko
    Hayashi, Saori
    Kawaji, Hitomi
    Mori, Masaki
    Oda, Yoshinao
    Nakamura, Masafumi
    ANTICANCER RESEARCH, 2021, 41 (08) : 4143 - 4149
  • [30] Reassessment of HER2 Status in Invasive Micropapillary Carcinoma of the Breast - Recommendations for Improvement of 2023 ASCO/CAP Guideline on HER2 Testing
    Li, Y.
    Zhang, M.
    Yue, M.
    Yuan, X.
    Liu, C.
    Li, X.
    Liu, Y.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 104 - 105
12345